WILLIAMS AND JENSEN, PLLC for ABBOTT LABORATORIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure legislation including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Federal preemption for drugs and devices including H.R. 1346/S. 540, Medical Device Safety Act of 2009; Health care reform; including the Affordable Health Choices Act ; Prescription drug advertising; Bisphenol A including S. 593; and congressional oversight issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN New | COS, Rep.Van Hilleary and Majority Whip DeLay |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax, including international tax proposals in FY 2010 Administration Budget proposal
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN New | COS, Rep.Van Hilleary and Majority Whip DeLay |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; Medicare drug payment and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN New | COS, Rep.Van Hilleary and Majority Whip DeLay |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.